Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07352618
NA

"Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus."

Sponsor: Bangladesh Medical University

View on ClinicalTrials.gov

Summary

The goal of this clinical trial is to learn if Omega-3 works to control glycemic status, improve lipid profile in Type2 Diabetic patients. It will also learn about the safety of drug Omega-3. The main questions it aims to answer are: Does drug Omega-3 control glycemic status, improve lipid profile in Type2 Diabetic patients? What medical problems do participants have when taking drug Omega-3? Researchers will compare Omega-3 to a placebo(a look-alike substance that contains no drug)to see if Omega-3 works to treat Type 2 Diabetic patients. Participants will take Omega-3 or a placebo twice daily for 12 weeks. Baseline and 12 weeks after FPG, HbA1c,Serum Lipid profile, Omega-3 level will be monitored.

Official title: "Effect of Omega-3 Supplementation as Add on Therapy on Glycemic Control and Lipid Profile in Type2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Trial"

Key Details

Gender

MALE

Age Range

25 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

66

Start Date

2026-01

Completion Date

2026-06

Last Updated

2026-01-21

Healthy Volunteers

No

Interventions

DIETARY_SUPPLEMENT

Omega-3 Fatty Acids

Participants received Omega-3 1gm capsule orally twice daily for 12 weeks

DIETARY_SUPPLEMENT

placebo

Participants received Omega-3 placebo capsule twice daily for 12 weeks

Locations (1)

Bangladesh Medical University

Dhaka, Bangladesh